Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15756)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 24, 2021 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chevallier M, Borgeaud M, Addeo A, Friedlaender A. Oncogenic driver mutations in non-small cell lung cancer: Past, present and future . World J Clin Oncol 2021; 12(4): 217-237 [PMID: 33959476 DOI: 10.5306/wjco.v12.i4.217] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i4/217.htm |
| Number | Citing Articles |
| 1 |
Akanksha Dessai, Usha Yogendra Nayak, Yogendra Nayak. Precision nanomedicine to treat non-small cell lung cancer. Life Sciences 2024; 346: 122614 doi: 10.1016/j.lfs.2024.122614
|
| 2 |
Mervat Mahrous, Abdalla Omar Jebriel, Ahmed Allehebi, Amr Shafik, Fadi El Karak, Filippo Venturini, Hamed Alhusaini, Matthias Meergans, Mehmet Ali Nahit Sendur, Mohamed Ouda, Muath Al-Nassar, Saadettin Kilickap, Saeed Al Turki, Turki Al-Fayea, Yasser Abdel Kader. Consensus Recommendations for the Diagnosis, Biomarker Testing, and Clinical Management of Advanced or Metastatic Non-small Cell Lung Cancer With Mesenchymal-Epithelial Transition Exon 14 Skipping Mutations in the Middle East, Africa, and Russia. Cureus 2023; doi: 10.7759/cureus.41992
|
| 3 |
Jerold Loh, Yvonne Li En Ang, Amit Jain, Joe Yeong, Raghav Sundar. Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies. JCO Precision Oncology 2022; (6) doi: 10.1200/PO.22.00208
|
| 4 |
Gabriella Gálffy, Éva Morócz, Réka Korompay, Réka Hécz, Réka Bujdosó, Rita Puskás, Tímea Lovas, Eszter Gáspár, Kamel Yahya, Péter Király, Zoltán Lohinai. Targeted therapeutic options in early and metastatic NSCLC-overview. Pathology and Oncology Research 2024; 30 doi: 10.3389/pore.2024.1611715
|
| 5 |
Ram Sharma, Esha Chatterjee, Jacob Mathew, Sachin Sharma, N. Vijayakameswara Rao, Chun-Hsu Pan, Sung-Bau Lee, Ashwani Dhingra, Ajmer S. Grewal, Jing Ping Liou, Santosh K. Guru, Kunal Nepali. Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier. European Journal of Medicinal Chemistry 2022; 240: 114602 doi: 10.1016/j.ejmech.2022.114602
|
| 6 |
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike. Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and Therapy 2023; : 465 doi: 10.2147/OTT.S404035
|
| 7 |
Simona Stefania Juncu, Anca Victorita Trifan, Horia Minea. From spotlight to shadow: ALK inhibitor-induced acute liver failure in a patient with non-small cell lung cancer. Archive of Clinical Cases 2023; 10(4): 160 doi: 10.22551/2023.41.1004.10266
|
| 8 |
Xuyang Song, Jinxi He, Bingqing Shi, Yuning Han, Yoke Keong Yong. Hypoxic Microenvironment-Induced Reduction in PTEN-L Secretion Promotes Non-Small Cell Lung Cancer Metastasis through PI3K/AKT Pathway. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6683104
|
| 9 |
Marianne Davies. Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice Nurse. Clinical Journal of Oncology Nursing 2022; 26(3): 245 doi: 10.1188/22.CJON.245-251
|
| 10 |
Anupa John, Vanita Noronha, Ajaykumar Singh, Nandini Menon, Kumar Prabhash. Amivantamab: A narrative drug review. Cancer Research, Statistics, and Treatment 2023; 6(2): 261 doi: 10.4103/crst.crst_166_23
|
| 11 |
Afshan Fathima Nawas, Ashley Solmonson, Boning Gao, Ralph J. DeBerardinis, John D. Minna, Maralice Conacci-Sorrell, Carole R. Mendelson. IL-1β mediates the induction of immune checkpoint regulators IDO1 and PD-L1 in lung adenocarcinoma cells. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01348-1
|
| 12 |
Danilo Rocco, Luigi Sapio, Luigi Della Gravara, Silvio Naviglio, Cesare Gridelli. Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes. International Journal of Molecular Sciences 2023; 24(3): 2433 doi: 10.3390/ijms24032433
|
| 13 |
Eurydice Angeli, Guilhem Bousquet. Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier. Pharmaceutics 2021; 13(9): 1446 doi: 10.3390/pharmaceutics13091446
|
| 14 |
Salman Alamery, Anfal AlAjmi, Tanveer A. Wani, Seema Zargar. In Silico and In Vitro Exploration of Poziotinib and Olmutinib Synergy in Lung Cancer: Role of hsa-miR-7-5p in Regulating Apoptotic Pathway Marker Genes. Medicina 2023; 59(11): 1923 doi: 10.3390/medicina59111923
|
| 15 |
Qiuqiang Chen, Gang Jia, Xilin Zhang, Wenxue Ma. Targeting HER3 to overcome EGFR TKI resistance in NSCLC. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1332057
|
| 16 |
Sarah J. Gao, Lan Jin, Hugh W. Meadows, Timothy D. Shafman, Cary P. Gross, James B. Yu, Hugo J.W. L. Aerts, Joseph A. Miccio, John M. Stahl, Raymond H. Mak, Roy H. Decker, Benjamin H. Kann. Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model. Journal of Thoracic Oncology 2023; 18(3): 339 doi: 10.1016/j.jtho.2022.11.007
|
| 17 |
Hanwen Wang, Theinmozhi Arulraj, Holly Kimko, Aleksander S. Popel. Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition. npj Precision Oncology 2023; 7(1) doi: 10.1038/s41698-023-00405-9
|
| 18 |
Federica Pezzuto, Véronique Hofman, Christophe Bontoux, Francesco Fortarezza, Francesca Lunardi, Fiorella Calabrese, Paul Hofman. The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?. Lung Cancer 2023; 181: 107249 doi: 10.1016/j.lungcan.2023.107249
|
| 19 |
Jessica S. Donington, Barbara Gitlitz, Eric Lim, Isabelle Opitz, Young Tae Kim, Nasser Altorki. Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. The Annals of Thoracic Surgery 2023; 115(6): 1544 doi: 10.1016/j.athoracsur.2022.09.029
|
| 20 |
A. L. Kornietskaya, L. V. Bolotina, S. F. Evdokimova, N. S. Prizova, Yu. B. Karagodina, V. V. Savchina, A. A. Fedenko. First-line treatment option for patients with ALK-positive metastatic NSCLC. Meditsinskiy sovet = Medical Council 2023; (22): 74 doi: 10.21518/ms2023-434
|
| 21 |
Ruth Moulson, Jennifer Law, Adrian Sacher, Geoffrey Liu, Frances A. Shepherd, Penelope Bradbury, Lawson Eng, Sandra Iczkovitz, Erica Abbie, Julia Elia-Pacitti, Emmanuel M. Ewara, Viktoriia Mokriak, Jessica Weiss, Christopher Pettengell, Natasha B. Leighl. Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence. Current Oncology 2024; 31(4): 1947 doi: 10.3390/curroncol31040146
|
| 22 |
Brandon S. Sheffield, Andrea Beharry, Joanne Diep, Kirstin Perdrizet, Marco A. J. Iafolla, William Raskin, Shaan Dudani, Mary Anne Brett, Blerta Starova, Brian Olsen, Parneet K. Cheema. Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care. Current Oncology 2022; 29(3): 1326 doi: 10.3390/curroncol29030113
|
| 23 |
Guowei Gong, Kumar Ganesan, Qingping Xiong, Yuzhong Zheng, Daniel Dias Rufino Arcanjo. Antitumor Effects of Ononin by Modulation of Apoptosis in Non-Small-Cell Lung Cancer through Inhibiting PI3K/Akt/mTOR Pathway. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/5122448
|
| 24 |
涤非 曹. Study on Driver Genes of Non-Small Cell Lung Cancer. Hans Journal of Biomedicine 2022; 12(01): 9 doi: 10.12677/HJBM.2022.121002
|
| 25 |
Cliff Molife, Katherine B. Winfree, Hollie Bailey, Yulia D’yachkova, Cameron Forshaw, Sangmi Kim, Kaisa-Leena Taipale, Tarun Puri. Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study. Advances in Therapy 2023; 40(7): 3135 doi: 10.1007/s12325-023-02530-0
|
| 26 |
Hippolyte Darré, Perrine Masson, Arnaud Nativel, Laura Villain, Diane Lefaudeux, Claire Couty, Bastien Martin, Evgueni Jacob, Michaël Duruisseaux, Jean-Louis Palgen, Claudio Monteiro, Adèle L’Hostis. Comparing the Efficacy of Two Generations of EGFR-TKIs: An Integrated Drug–Disease Mechanistic Model Approach in EGFR-Mutated Lung Adenocarcinoma. Biomedicines 2024; 12(3): 704 doi: 10.3390/biomedicines12030704
|
| 27 |
Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W. McDermott, Manmeet S. Ahluwalia. Management of Brain Metastases: A Review of Novel Therapies. Seminars in Neurology 2023; 43(06): 845 doi: 10.1055/s-0043-1776782
|
| 28 |
Hafiza Padinharayil, Reema Rose Alappat, Liji Maria Joy, Kavya V. Anilkumar, Cornelia M. Wilson, Alex George, Abilash Valsala Gopalakrishnan, Harishkumar Madhyastha, Thiyagarajan Ramesh, Ezhaveni Sathiyamoorthi, Jintae Lee, Raja Ganesan. Advances in the Lung Cancer Immunotherapy Approaches. Vaccines 2022; 10(11): 1963 doi: 10.3390/vaccines10111963
|
| 29 |
Rebecca Ibrahim, Claude Chahine, Tony Felefly, Nadine Khalife, Khalil Saleh. The CLIP1–LTK fusion: a new oncogenic driver in non-small-cell lung cancer?. Future Oncology 2023; 19(4): 273 doi: 10.2217/fon-2022-1232
|
| 30 |
Jayson R. Nelson, Derek J. Matheson, Oluwaseun E. Omoba, Candace L. Winterton, Clayton D. Rawson, Elena M. Kurudza, Brandon P. Lucke-Wold. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_236
|
| 31 |
Prerana Jha, Vaishakhi Trivedi, Ranendra Biswal, Pratik Chandrani, Venkataramanan Ramachandran, Minit Shah, Anuradha Choughule, Vanita Noronha, Kumar Prabhash, Prashant Kumar. Identification of a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing as a tool for precision medicine. Cancer Research, Statistics, and Treatment 2023; 6(4): 589 doi: 10.4103/crst.crst_287_23
|
| 32 |
Kazunori Aoki, Yukari Nishito, Noriko Motoi, Yasuhito Arai, Nobuyoshi Hiraoka, Tatsuhiro Shibata, Yukiko Sonobe, Yoko Kayukawa, Eri Hashimoto, Mina Takahashi, Etsuko Fujii, Takashi Nishizawa, Hironori Fukuda, Kana Ohashi, Kosuke Arai, Yukihiro Mizoguchi, Yukihiro Yoshida, Shun-ichi Watanabe, Makiko Yamashita, Shigehisa Kitano, Hiromi Sakamoto, Yuki Nagata, Risa Mitsumori, Kouichi Ozaki, Shumpei Niida, Yae Kanai, Akiyoshi Hirayama, Tomoyoshi Soga, Toru Maruyama, Keisuke Tsukada, Nami Yabuki, Mei Shimada, Takehisa Kitazawa, Osamu Natori, Noriaki Sawada, Atsuhiko Kato, Teruhiko Yoshida, Kazuki Yasuda, Hideaki Mizuno, Hiroyuki Tsunoda, Atsushi Ochiai. Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations. Cancer Research Communications 2023; 3(6): 1026 doi: 10.1158/2767-9764.CRC-22-0415
|
| 33 |
Bongyong Lee, Andrew Chern, Andrew Y. Fu, Aiguo Zhang, Michael Y. Sha. A Highly Sensitive XNA-Based RT-qPCR Assay for the Identification of ALK, RET, and ROS1 Fusions in Lung Cancer. Diagnostics 2024; 14(5): 488 doi: 10.3390/diagnostics14050488
|
| 34 |
Iwona Ziółkowska-Suchanek, Magdalena Żurawek. FOXP3: A Player of Immunogenetic Architecture in Lung Cancer. Genes 2024; 15(4): 493 doi: 10.3390/genes15040493
|
| 35 |
Dong Hoon Shin, Jeong Yeon Jo, Minyoung Choi, Kyung-Hee Kim, Young-Ki Bae, Sang Soo Kim. Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer. Experimental & Molecular Medicine 2023; 55(10): 2220 doi: 10.1038/s12276-023-01091-0
|
| 36 |
Wan-Li Cheng, Po-Hao Feng, Kang-Yun Lee, Kuan-Yuan Chen, Wei-Lun Sun, Nguyen Van Hiep, Ching-Shan Luo, Sheng-Ming Wu. The Role of EREG/EGFR Pathway in Tumor Progression. International Journal of Molecular Sciences 2021; 22(23): 12828 doi: 10.3390/ijms222312828
|
| 37 |
Xavier Baer, Mathieu Chevallier, Juliana Rey Cobo, Jérôme Plojoux, Claudio De Vito, Alfredo Addeo. Rare Synchronous Lung Cancers in a Nonsmoker with Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition Alterations: A Case Report. Case Reports in Oncology 2024; : 549 doi: 10.1159/000538019
|
| 38 |
Marisa L. Martin-Fernandez. Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer. Cancers 2022; 14(3): 686 doi: 10.3390/cancers14030686
|
| 39 |
Trine V. Larsen, Christoffer T. Maansson, Tina F. Daugaard, Brage S. Andresen, Boe S. Sorensen, Anders L. Nielsen. Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells. Cells 2023; 12(24): 2844 doi: 10.3390/cells12242844
|
| 40 |
Geoffrey Liu, Julien Mazieres, Jan Stratmann, Sai-Hong Ignatius Ou, Tony Mok, Mary Grizzard, Yasushi Goto, Enriqueta Felip, Benjamin J. Solomon, Todd M. Bauer. A pragmatic guide for management of adverse events associated with lorlatinib. Lung Cancer 2024; 191: 107535 doi: 10.1016/j.lungcan.2024.107535
|
| 41 |
Izzet Dogan, Nijat Khanmammadov, Melin Aydan Ahmed, Anıl Yıldız, Pinar Saip, Adnan Aydiner, Sezai Vatansever. Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib. Clinical Cancer Investigation Journal 2022; 11(4): 5 doi: 10.51847/rvQeWyfFBI
|
| 42 |
Alissa J. Cooper, Lecia V. Sequist, Ted W. Johnson, Jessica J. Lin. LTK fusions: A new target emerges in non-small cell lung cancer. Cancer Cell 2022; 40(1): 23 doi: 10.1016/j.ccell.2021.12.012
|
| 43 |
K.K. Lactionov, E.V. Reutova, A.E. Gorokhov, A.M. Fedun, T.F. Ibragimov, D.L. Stroyakovski, G.B. Statsenko. Approaches to the diagnosis and treatment of patients with stage III—IV non-small cell lung cancer in Russia. Preliminary results of a prospective multicenter non-interventional observational study KARL. Onkologiya. Zhurnal imeni P.A.Gertsena 2023; 12(6): 33 doi: 10.17116/onkolog20231206133
|
| 44 |
Meifang Liu, Jie Yang, Lagen Wan, Rui Zhao. Elevated Pretreatment Fibrinogen-to-Lymphocyte Percentage Ratio Predict Tumor Staging and Poor Survival in Non-Small Cell Lung Cancer Patients with Chemotherapy or Surgery Combined with Chemotherapy. Cancer Management and Research 2021; : 4921 doi: 10.2147/CMAR.S308659
|
| 45 |
Alessandro La Ferlita, Rosario Distefano, Salvatore Alaimo, Joal D. Beane, Alfredo Ferro, Carlo M. Croce, Philip N. Tsichlis, Alfredo Pulvirenti, Giovanni Nigita. Transcriptome Analysis of Human Endogenous Retroviruses at Locus-Specific Resolution in Non-Small Cell Lung Cancer. Cancers 2022; 14(18): 4433 doi: 10.3390/cancers14184433
|
| 46 |
Christine M. Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He, Julie Vanderpoel. Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of Medical Economics 2024; 27(1): 292 doi: 10.1080/13696998.2024.2314430
|
| 47 |
Thomas Yang Sun, Millie Das. Lung Cancer. Respiratory Medicine 2023; : 165 doi: 10.1007/978-3-031-38412-7_8
|
| 48 |
Yi-Long Wu, Rafal Dziadziuszko, Jin Seok Ahn, Fabrice Barlesi, Makoto Nishio, Dae Ho Lee, Jong-Seok Lee, Wenzhao Zhong, Hidehito Horinouchi, Weimin Mao, Maximilian Hochmair, Filippo de Marinis, M. Rita Migliorino, Igor Bondarenko, Shun Lu, Qun Wang, Tania Ochi Lohmann, Tingting Xu, Andres Cardona, Thorsten Ruf, Johannes Noe, Benjamin J. Solomon.
Alectinib in Resected
ALK
-Positive Non–Small-Cell Lung Cancer
. New England Journal of Medicine 2024; 390(14): 1265 doi: 10.1056/NEJMoa2310532
|
| 49 |
Sethi Ashish, Robin R Rodriguez, Purva Sethi, Fang Yu, Moses Raj. Anaplastic Lymphoma Kinase (ALK) Mutation-Targeting Treatment With Alectinib in Lung Adenocarcinoma and Primary Cutaneous Marginal Zone B-Cell Lymphoma. Cureus 2022; doi: 10.7759/cureus.29922
|
| 50 |
Harsh Sahu. Amivantamab in non-small-cell lung cancer. Cancer Research, Statistics, and Treatment 2023; 6(3): 486 doi: 10.4103/crst.crst_261_23
|
| 51 |
Showkat Ahmad Mir, Prajna Paramita Mohanta, Rajesh Kumar Meher, Iswar baitharu, Mukesh Kumar Raval, Ajaya Kumar Behera, Binata Nayak. Structural insights into conformational stability and binding of thiazolo-[2,3-b] quinazolinone derivatives with EGFR-TKD and in-vitro study. Saudi Journal of Biological Sciences 2022; 29(12): 103478 doi: 10.1016/j.sjbs.2022.103478
|
| 52 |
Ajaykumar Singh, Vijay Patil, Nandini Menon, Sucheta More, Srushti Jain, Supriya Goud, Darshit Shah, Minit Shah, Kunal Jobanputra, Ahmad Ubharay. Phase III randomized controlled trial of gefitinib versus chemotherapy in EGFR-positive treatment-naïve metastatic lung cancer: Long-term outcome after eight years. Cancer Research, Statistics, and Treatment 2024; 7(1): 19 doi: 10.4103/crst.crst_307_23
|
| 53 |
Navdeep Dehar, Tasnima Abedin, Patricia Tang, Gwyn Bebb, Winson Y. Cheung. A Comparison of Patients’ and Physicians’ Knowledge and Expectations Regarding Precision Oncology Tests. Current Oncology 2022; 29(12): 9916 doi: 10.3390/curroncol29120780
|
| 54 |
Julien Mazieres, Helene Vioix, Boris M. Pfeiffer, Rhiannon I. Campden, Zhiyuan Chen, Bart Heeg, Alexis B. Cortot. MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes. Clinical Lung Cancer 2023; 24(6): 483 doi: 10.1016/j.cllc.2023.06.008
|
| 55 |
Da Som Jeon, Cheol‐kyu Park, Seung Joon Kim, Chan Kwon Park, Yoon Soo Chang, Chi Young Jung, Sung Yong Lee, Shin‐Yup Lee, Jeong‐Seon Ryu, Jeong Eun Lee, Kye Young Lee, Tae Won Jang, Seung Hun Jang, Seong Hoon Yoon, Sang Hoon Lee, Chang‐min Choi, Hyeong Ryul Kim, Yeon Joo Kim. Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea. Thoracic Cancer 2024; 15(6): 448 doi: 10.1111/1759-7714.15213
|
| 56 |
Vikram Sumbly, Ian Landry. Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer. Cureus 2022; doi: 10.7759/cureus.21078
|
| 57 |
Bogdan Cosmin Tanase, Alin Ionut Burlacu, Claudiu Eduard Nistor, Teodor Horvat, Cristian Oancea, Monica Marc, Emanuela Tudorache, Tudor Mateescu, Diana Manolescu. A Retrospective Analysis Comparing VATS Cost Discrepancies and Outcomes in Primary Lung Cancer vs. Second Primary Lung Cancer Patients. Healthcare 2023; 11(12): 1745 doi: 10.3390/healthcare11121745
|
| 58 |
Qianqian Guo, Liwei Liu, Zelong Chen, Yannan Fan, Yang Zhou, Ziqiao Yuan, Wenzhou Zhang. Current treatments for non-small cell lung cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.945102
|
| 59 |
Carmen María Valencia Soto, Virginia Martínez Callejo, Adela García-Avello Fernández-Cueto, María Victoria Villacañas Palomares, Sara Barbadillo Villanueva, María Ochagavía Sufrategui, Marta Francisca López-Brea Piqueras, Marta Valero Domínguez. Severe hepatotoxicity during treatment with capmatinib. Journal of Oncology Pharmacy Practice 2023; 29(6): 1484 doi: 10.1177/10781552231173120
|
| 60 |
Prerana Jha, Vaishakhi Trivedi, Pooja Mahesh Kulkarni, Simran Rai, Minit Shah, Pratik Chandrani, Anuradha Choughule, Venkataramanan Ramachandran, Vanita Noronha, Kumar Prabhash, Prashant Kumar. Targeted next generation sequencing (NGS) enables identification of rare EGFR exon-20 insertion (p.H773_V774insPHPH) in lung adenocarcinoma patient. Medical Reports 2023; 2: 100018 doi: 10.1016/j.hmedic.2023.100018
|
| 61 |
Izzet Dogan, Nijat Khanmammadov, Melin Aydan Ahmed, Anıl Yıldız, Pinar Saip, Adnan Aydiner, Sezai Vatansever. Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience. Clinical Cancer Investigation Journal 2022; 11(3): 25 doi: 10.51847/87N2FdDtB1
|
| 62 |
Yijiang Shi, Daniel Sanghoon Shin. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy. Biomolecules 2023; 13(6): 984 doi: 10.3390/biom13060984
|
| 63 |
Hongyuan Liang, Lingyun Zhang, Jian Rong. Potential roles of exosomes in the initiation and metastatic progression of lung cancer. Biomedicine & Pharmacotherapy 2023; 165: 115222 doi: 10.1016/j.biopha.2023.115222
|
| 64 |
Julian M. Rozenberg, Gleb I. Filkov, Alexander V. Trofimenko, Evgeny A. Karpulevich, Vladimir D. Parshin, Valery V. Royuk, Marina I. Sekacheva, Mikhail O. Durymanov. Biomedical Applications of Non-Small Cell Lung Cancer Spheroids. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.791069
|
| 65 |
Ameish Govindarajan. Chasing Milestones. Journal of Clinical Oncology 2023; 41(8): 1626 doi: 10.1200/JCO.22.01379
|
| 66 |
Guiping Yu, Yiqi Chen, Yuwen Hu, Yan Zhou, Xiaoling Ding, Xiaorong Zhou. Roles of transducin-like enhancer of split (TLE) family proteins in tumorigenesis and immune regulation. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.1010639
|
| 67 |
Alessandro Di Federico, Ilaria Ricciotti, Valentina Favorito, Sandra Vietti Michelina, Pietro Scaparone, Giulio Metro, Andrea De Giglio, Federica Pecci, Giuseppe Lamberti, Chiara Ambrogio, Biagio Ricciuti. Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer. Current Oncology Reports 2023; 25(9): 1017 doi: 10.1007/s11912-023-01436-y
|
| 68 |
Kenneth S. Ramos, Abeer A.I. Hassanin, Yingshan Wang. Comprehensive Precision Medicine. 2024; : 465 doi: 10.1016/B978-0-12-824010-6.00034-4
|
| 69 |
Kenta Ninomiya, Hidetaka Arimura, Kentaro Tanaka, Wai Yee Chan, Yutaro Kabata, Shinichi Mizuno, Nadia Fareeda Muhammad Gowdh, Nur Adura Yaakup, Chong-Kin Liam, Chee-Shee Chai, Kwan Hoong Ng. Three-dimensional topological radiogenomics of epidermal growth factor receptor Del19 and L858R mutation subtypes on computed tomography images of lung cancer patients. Computer Methods and Programs in Biomedicine 2023; 236: 107544 doi: 10.1016/j.cmpb.2023.107544
|
| 70 |
Urska Janzic, Walid Shalata, Katarzyna Szymczak, Rafał Dziadziuszko, Marko Jakopovic, Giannis Mountzios, Adam Płużański, Antonio Araujo, Andriani Charpidou, Abed Agbarya. Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations. International Journal of Molecular Sciences 2023; 24(16): 12840 doi: 10.3390/ijms241612840
|
| 71 |
Kenta Ninomiya, Hidetaka Arimura, Kentaro Tanaka, Wai Yee Chan, Yutaro Kabata, Shinichi Mizuno, Nadia Muhammad Gowdh, Nur Adura Yaakup, Chong Kin Liam, Chee-Shee Chai, Kwan Hoong Ng. Three-Dimensional Topological Radiogenomics of Epidermal Growth Factor Receptor Del19 and L858R Mutation Subtypes on Computed Tomography Images of Lung Cancer Patients. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4093528
|
| 72 |
Nasim Ebrahimi, Elmira Fardi, Hajarossadat Ghaderi, Sahar Palizdar, Roya Khorram, Reza Vafadar, Masoud Ghanaatian, Fatemeh Rezaei-Tazangi, Payam Baziyar, Amirhossein Ahmadi, Michael R. Hamblin, Amir Reza Aref. Receptor tyrosine kinase inhibitors in cancer. Cellular and Molecular Life Sciences 2023; 80(4) doi: 10.1007/s00018-023-04729-4
|
| 73 |
Ayaka Saito, Hideki Terai, Tae‐Jung Kim, Katsura Emoto, Ryutaro Kawano, Kohei Nakamura, Hideyuki Hayashi, Hatsuyo Takaoka, Akihiko Ogata, Katsuhito Kinoshita, Fumimaro Ito, Lisa Shigematsu, Masahiko Okada, Takahiro Fukushima, Akifumi Mitsuishi, Taro Shinozaki, Keiko Ohgino, Shinnosuke Ikemura, Hiroyuki Yasuda, Ichiro Kawada, Kenzo Soejima, Hiroshi Nishihara, Koichi Fukunaga. Clinical utility of the Oncomine Dx Target Test multi‐CDx system and the possibility of utilizing those original sequence data. Cancer Medicine 2024; 13(4) doi: 10.1002/cam4.7077
|
| 74 |
Rachael Batteson, Emma Hook, Hollie Wheat, Anthony J. Hatswell, Helene Vioix, Thomas McLean, Stamatia Theodora Alexopoulos, Shobhit Baijal, Paul K. Paik. Modelling the Effectiveness of Tepotinib in Comparison to Standard-of-Care Treatments in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Harbouring METex14 Skipping in the UK. Targeted Oncology 2024; 19(2): 191 doi: 10.1007/s11523-024-01038-z
|
| 75 |
Dingani Nkosi, Giby V. George, Huijie Liu, Meghan Buldo, Moises J. Velez, Zoltán N. Oltvai. Efficient Lung Cancer Molecular Diagnostics by Combining Next Generation Sequencing with Reflex Idylla Genefusion Assay Testing. Genes 2023; 14(8): 1551 doi: 10.3390/genes14081551
|
| 76 |
Sara Salucci, Beatrice Aramini, Anna Bartoletti-Stella, Ilaria Versari, Giovanni Martinelli, William Blalock, Franco Stella, Irene Faenza. Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches. Cancers 2023; 15(12): 3245 doi: 10.3390/cancers15123245
|
| 77 |
Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby. HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies. Life 2023; 14(1): 64 doi: 10.3390/life14010064
|
| 78 |
Federica Cosso, Giandomenico Roviello, Martina Catalano, Cristina Botteri, Camilla Eva Comin, Francesca Castiglione, Katia Ferrari, Editta Baldini, Enrico Mini. A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin. Anti-Cancer Drugs 2024; 35(1): 76 doi: 10.1097/CAD.0000000000001517
|
| 79 |
S. Shukla, A. Karbhari, S. Rastogi, U. Agarwal, P. Rai, A. Mahajan. Bench-to-bedside imaging in brain metastases: a road to precision oncology. Clinical Radiology 2024; doi: 10.1016/j.crad.2024.02.015
|
| 80 |
Dasom Kim, Dongwha Min, Joohee Kim, Min Jung Kim, Yerim Seo, Byung Hwa Jung, Seung‑Hae Kwon, Hyunju Ro, Seoee Lee, Jason K. Sa, Ji-Yun Lee. Nutlin-3a induces KRAS mutant/p53 wild type lung cancer specific methuosis-like cell death that is dependent on GFPT2. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02922-8
|
| 81 |
Elisa De Carlo, Elisa Bertoli, Alessandro Del Conte, Brigida Stanzione, Eleonora Berto, Alberto Revelant, Michele Spina, Alessandra Bearz. Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era. International Journal of Molecular Sciences 2022; 23(12): 6477 doi: 10.3390/ijms23126477
|
| 82 |
Marton Gyulai, Zsolt Megyesfalvi, Lilla Reiniger, Tunde Harko, Bence Ferencz, Luca Karsko, Laszlo Agocs, Janos Fillinger, Balazs Dome, Zoltan Szallasi, Judit Moldvay. PD-1 and PD-L1 expression in rare lung tumors. Pathology and Oncology Research 2023; 29 doi: 10.3389/pore.2023.1611164
|
| 83 |
Izzet Dogan, Nijat Khanmammadov, Anıl Yıldız, Melin Aydan Ahmed, Sezai Vatansever, Pinar Saip, Adnan Aydiner. Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors. Journal of Cancer Research and Therapeutics 2023; 19(7): 1945 doi: 10.4103/jcrt.jcrt_877_22
|
| 84 |
James E. Frampton. Osimertinib: A Review in Completely Resected, Early-Stage, EGFR Mutation-Positive NSCLC. Targeted Oncology 2022; 17(3): 369 doi: 10.1007/s11523-022-00883-0
|
| 85 |
Alessia Salzillo, Angela Ragone, Annamaria Spina, Silvio Naviglio, Luigi Sapio. Forskolin affects proliferation, migration and Paclitaxel-mediated cytotoxicity in non-small-cell lung cancer cell lines via adenylyl cyclase/cAMP axis. European Journal of Cell Biology 2023; 102(2): 151292 doi: 10.1016/j.ejcb.2023.151292
|
| 86 |
Anggraeni E. Kusumaningrum, Sarce Makaba, Eyhab Ali, Mandeep Singh, Mohammed N. Fenjan, Irodakhon Rasulova, Neeti Misra, Sada G. Al‐ Musawi, Ali Alsalamy. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance. Cell Biochemistry and Function 2024; 42(1) doi: 10.1002/cbf.3906
|